HomeSourcesHow Do I?OverviewHelpLogo
[Return to Search][Focus]
Search Terms: vaccine, tax credit

[Document List][Expanded List][KWIC][FULL]

[Previous Document] Document 18 of 31. [Next Document]

Copyright 2000 Globe Newspaper Company  
The Boston Globe

 View Related Topics 

February 25, 2000, Friday ,THIRD EDITION

SECTION: NATIONAL/FOREIGN; Pg. A8

LENGTH: 376 words

HEADLINE: BILL OFFERS INCENTIVES FOR MALARIA, AIDS, TUBERCULOSIS VACCINES

BYLINE: By John Donnelly, Globe Staff

BODY:
WASHINGTON - Alarmed by the "death spiral" from AIDS, tuberculosis, and malaria in Africa, US Senator John Kerry yesterday proposed a $150 million plan laden with tax credits to spur research for development of vaccines against those diseases.

"This grew out of my awareness in the last year and a half of the incredible level of devastation in Africa," the Massachusetts Democrat said last night. "It's unacceptable for any country to sit by while that is going on. It's a human catastrophe beyond belief."   Called the Vaccines for the New Millennium Act, Kerry's proposal also is aimed at encouraging research by increasing a tax credit to 50 percent from the current 20 percent as well as giving tax credits for the sales of new vaccines for malaria, TB, or HIV/AIDS.

Kerry said incentives for private companies were a key part of the bill. Quoting World Bank figures, he noted that of the $250 million to $350 million spent on research for AIDS last year, the industry funded less than $52 million.

Last year, AIDS, TB, and malaria killed 5.2 million people. Africa alone has an estimated 40 million orphans due to deaths from AIDS.

Kerry's proposal is part of a larger movement toward assistance for African countries. Last November, the Bill & Melinda Gates Foundation announced a $750 million grant to the Global Alliance for Vaccines and Immunizations. And Kerry also is one of the co sponsors of a bill that would put $2 billion in new funding toward treatment for HIV/AIDS in Africa.

While medical providers applauded Kerry's vaccination bill yesterday, some said that much more money is needed to treat those with the diseases.

"There can't be this constant struggle between vaccine development and therapy," said Paul Farmer, director of Harvard Medical School's Program in Infectious Disease and Social Change. "That's what we have now - a cat fight between people who should be working together to prevent and treat these diseases."

Kerry responded: "There won't be a fight. There will funding for both treatment and research."

Farmer was skeptical. "When this becomes a foreign policy priority of the United States, then the sums disbursed will be at least 10 times as great as those proposed."

LOAD-DATE: March 4, 2000




[Previous Document] Document 18 of 31. [Next Document]


FOCUS

Search Terms: vaccine, tax credit
To narrow your search, please enter a word or phrase:
   
About Terms and Conditions Top of Page
Copyright© 2001, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.